Headquartered in Brea, CA, Beckman Coulter, a manufacturer of diagnostic products, is actively considering establishing a manufacturing facility in India as part of its long-term market expansion strategy. Currently, the company is engaged in discussions with its global business unit to initiate production of consumer goods within the country.
As a subsidiary of the Danaher Corporation, Beckman Coulter aims to concentrate on business-to-consumer operations and automation, fostering closer collaboration with healthcare providers directly involved in patient care. The company’s core business strategy is centered around creating value through simplified and automated laboratory solutions designed to enhance patient outcomes and contribute positively to the healthcare landscape.
Beckman Coulter’s Indian subsidiary, Beckman Coulter India (BCIPL), currently employs a workforce of 300 individuals. Additionally, the India Development Center, located in Bangalore and affiliated with BCIPL, serves as a global research and development hub for the company, with a team of 800 professionals primarily focused on hardware and software testing to support its international portfolio.
The proposed manufacturing facility in India will initially focus on producing consumer goods, aligning with Beckman Coulter’s strategic shift towards business-to-consumer operations and automation. This move demonstrates the company’s dedication to streamlining laboratory processes, enhancing patient outcomes, and fostering closer collaboration with healthcare providers on the front lines of patient care.
